Key BIOS facts and Figures – 2025

Streamlining Biosimilar Development: Key Aspects

Biosimilars in the EU: Approval Overview and Therapeutic Areas

European Critical Medicines Act

Key BIOS facts and Figures – 2024

Infographic – Medicines Shortages: root causes and policies recommendations

It’s time to protect our medicines!

Infographic – Medicines Manufacturing

<strong><a class=”button small empty” href=”https://www.medicinesforeurope.com/wp-content/uploads/2023/05/Man-campaign-2022.png”>Open</a></strong>

One- Pager: New pricing models for generic medicines

How can we ensure a sustainable healthcare system while safeguarding continuous patient access to medicines?

Open

From disruption to care for cancer patients

Biosimilar medicines are biologic medicines that can be used safely and effectively in oncology and other therapy areas. Some of these medicines are so important that they are included in the WHO essential medicines list.

Open